Head-to-head · Value Score
CoreAge Rx vs Care Bare Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Care Bare Rx a 73. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameCare Bare Rx
#38 · Grade C+ · Watch List
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 73 — an est. $149/mo first month, with no teaser step-up baked in. Care Bare Rx isn't out of it: Shoppers who want oral tirzepatide or a brand lane and will trade price transparency for it.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Care Bare Rx |
|---|---|---|
| Value Score | 93 (A+) | 73 (C+) |
| Est. first month | $149/mo | $199/mo |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $149/mo | From $199/mo (shared weight-loss price) |
| Tirzepatide | $349/mo | From $199/mo (shared weight-loss price) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Care Bare Rx
Broad formulary including oral tirzepatide and brand Ozempic, but you cannot price a dose without entering the intake.
Why it's a deal
- Oral tirzepatide as well as injectable — rare on this board
- Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
- LegitScript certified and HIPAA compliant
The fine print
- The "from $199/mo" is shared across all weight-loss treatments — neither molecule is priced on its own
- Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
- No named clinicians, founding year or parent company disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.